PTGX Protagonist Therapeutics Inc

held by 1 manager in Q3 2025

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.27%	3 mo	NEW	$11M	159,700

Search